|Videos|July 8, 2021
Realizing the Advantages of Blow-Fill-Seal, Part One
Author(s)Apiject
In part one of a two-part series on blow-fill-seal, Beth Totin of ApiJect discusses how innovative blow-fill-seal/pre-filled syringe (BFS/PFS) technology is becoming a competitive advantage in today’s marketplace.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/16bc98940a34f0991f9ca5e7ccbfa6889fec078f-1634x909.jpg?w=350&fit=crop&auto=format)
![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/01d391920288b8bd8b751988988b5a6544a6ddaa-1629x908.jpg?w=350&fit=crop&auto=format)
![[Nigel Langley]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/e2c0137d8224aaa1f14c0f1af43b58d21f4541dd-1768x904.jpg?w=350&fit=crop&auto=format)
Trending on Pharmaceutical Technology
1
How ten23 health is Advancing Patient-Centric Drug Delivery
2
FDA, Duke University Planning Epinephrine Access Workshop for December
3
Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II
4
PharmTech Weekly News Roundup — Week of November 24, 2025
5
